Is SYNI or EPRT a better dividend investment in 2026?

SYNI currently yields 200000000.00% with a 5% 5-year dividend growth rate. EPRT yields 3.97% with 5% growth. The better choice depends on your goal: SYNI offers higher current income.

What is the dividend yield difference between SYNI and EPRT?

SYNI has a forward dividend yield of 200000000.00% ($2.00/share annually). EPRT yields 3.97% ($1.21/share annually). The yield gap is 199999996.03 percentage points.

Home › Compare › SYNI vs EPRT

SYNI vs EPRT: Dividend Comparison 2026

SYNI yields 200000000.00% · EPRT yields 3.97%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SYNI wins by $4.875657285131069e+59M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SYNI

● Live price

200000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.875657285131069e+59M

Annual income

$487,565,248,955,786,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00

Full SYNI calculator →

EPRT

● Live price

3.97%

Share price

$30.36

Annual div

$1.21

5Y div CAGR

29%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$64.3K

Annual income

$13,170.85

Full EPRT calculator →

Portfolio growth — SYNI vs EPRT

📍 SYNI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SYNI	EPRT
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SYNI + EPRT cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SYNI pays

EPRT pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYNI

Annual income on $10K today (after 15% tax)

$17,000,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$414,430,461,612,418,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

EPRT

Annual income on $10K today (after 15% tax)

$337.37/yr

After 10yr DRIP, annual income (after tax)

$11,195.22/yr

At 15% tax rate, SYNI beats the other by $414,430,461,612,418,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYNI + EPRT for your $10,000?

SYNI: 50%EPRT: 50%

100% EPRT50/50100% SYNI

Portfolio after 10yr

$2.4378286425655345e+59M

Annual income

$243,782,624,477,893,130,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

100.00%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

SYNI

No analyst data

EPRT

Analyst Ratings

Strong

Buy

Hold

Sell

Consensus: Buy

Price Target

$35.50

+16.9% upside vs current

Range: $33.00 — $37.00

Altman Z

1.8

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYNI buys

EPRT buys

No recent congressional trades found for SYNI or EPRT in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSYNIEPRT

Forward yield	200000000.00% ✓	3.97%
Annual dividend / share	$2.00 ✓	$1.21
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	29% ✓
Portfolio after 10y	$4.875657285131069e+59M	$64.3K ✓
Annual income after 10y	$487,565,248,955,786,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00 ✓	$13,170.85
Total dividends collected	$4.875656971401711e+59M	$38.7K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: SYNI vs EPRT ($10,000, DRIP)

Year	SYNI Portfolio	SYNI Income/yr	EPRT Portfolio	EPRT Income/yr	Gap
1← crossover	$20,000,010,700	$20,000,000,000.00	$11,212	$512.01	+$20000.00M → SYNI
2	$37,383,218,970,104,910	$37,383,197,570,093,464.00	$12,689	$692.09	+$37383218970.09M → SYNI
3	$65,303,942,472,059,150,000,000	$65,303,902,472,014,860,000,000.00	$14,521	$944.30	+$65303942472059152.00M → SYNI
4	$106,615,009,060,306,890,000,000,000,000	$106,614,939,185,088,440,000,000,000,000.00	$16,841	$1,302.88	+$1.0661500906030689e+23M → SYNI
5	$162,672,273,967,082,950,000,000,000,000,000,000	$162,672,159,889,023,270,000,000,000,000,000,000.00	$19,841	$1,821.64	+$1.6267227396708296e+29M → SYNI
6	$231,966,340,306,755,300,000,000,000,000,000,000,000,000	$231,966,166,247,422,140,000,000,000,000,000,000,000,000.00	$23,818	$2,587.47	+$2.319663403067553e+35M → SYNI
7	$309,138,182,305,146,600,000,000,000,000,000,000,000,000,000,000	$309,137,934,101,162,400,000,000,000,000,000,000,000,000,000,000.00	$29,230	$3,744.65	+$3.091381823051466e+41M → SYNI
8	$385,031,777,252,258,400,000,000,000,000,000,000,000,000,000,000,000,000	$385,031,446,474,403,340,000,000,000,000,000,000,000,000,000,000,000,000.00	$36,816	$5,540.38	+$3.850317772522584e+47M → SYNI
9	$448,184,411,799,345,900,000,000,000,000,000,000,000,000,000,000,000,000,000,000	$448,183,999,815,344,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00	$47,806	$8,413.17	+$4.481844117993459e+53M → SYNI
10	$487,565,728,513,106,900,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000	$487,565,248,955,786,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00	$64,324	$13,170.85	+$4.875657285131069e+59M → SYNI

SYNI vs EPRT: Complete Analysis 2026

SYNI — Stock

Synvista Therapeutics, Inc., a product-based biopharmaceutical company, develops diagnostic tests and drugs to identify and treat diabetic patients at high risk for the development of cardiovascular disease. The company's products include ALT-2074, a glutathione peroxidase mimetic in Phase II clinical trials for the treatment of diabetic patients with Hp2-2; and Alagebrium chloride or alagebrium, an Advanced Glycation End-product Crosslink Breaker in Phase II clinical trials for the treatment of diastolic heart failure and diabetic nephropathy. It is also developing a diagnostic test to identify and treat patients with diabetes who are in risk of cardiovascular disease. The company, formerly known as Alteon, Inc., was founded in 1986 and is headquartered in Montvale, New Jersey.

Full SYNI Calculator →

EPRT — REIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →

📬

Get this SYNI vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYNI vs SCHD SYNI vs JEPI SYNI vs O SYNI vs KO SYNI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.